Cynosure Names David Long Global Chief Financial Officer

Until recently, Long served as CFO at Corindus Vascular Robotics, Inc.

David Long is Cynosure’s new Chief Financial Officer, effective immediately.

Until recently, Long served as CFO at Corindus Vascular Robotics, Inc., where he brought the company public and, ultimately, navigated its strategic sale to Siemens. Prior to his time at Corindus, Long spent nearly a decade at Thermo Fisher Scientific, where he held the position of Vice President of Finance of the Laboratory Equipment Division. Long also served as an adjunct professor in the Department of Accountancy at Bentley University.

"I'm excited to join such a strong team of leaders," Long says in a news release. "I'm eager to get to work and make an impact alongside the leadership team to ensure we remain positioned for continued success and deliver the market-leading technology clinicians and consumers rely on from Cynosure."

Long holds a Master of Public Administration from the University of Pennsylvania and a Bachelor of Science in Finance from the University of Massachusetts.

"This is an exciting time as we look to position Cynosure for long-term sustainable growth and we're thrilled to have David join the team," adds Todd Tillemans. Cynosure’s Chief Executive Officer and former Hershey and Unilever executive. "He is a highly respected finance leader who will be invaluable as we prioritize investments in new innovation to drive our customers' businesses, and ultimately provide patients around the globe with best-in-class technology and service."